author-photo

Dirk Behringer

University of Freiburg

87

Papers

2133

Citations

Citation Trend

Filter By

Papers (63) Sort By

Journal Conference Others

Behandlung im Voraus Planen – ein Praxisprojekt zur Implementierung vorausschauender Versorgungsplanung in einer onkologischen Abteilung

2021
Show All
- Source
- Cite
- Save
Citations (0)
1871TiP PLATON – “Platform for Analyzing Targetable Tumor Mutations”: A pilot study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Rationale and Design of GnG-Trial: A Randomized Phase-III Study to Compare Two Schedules of Gemtuzumab Ozogamicin as Adjunct to Intensive Induction Therapy and to Compare Double-Blinded Intensive Postremission Therapy with or Without Glasdegib in Older Patients with Newly Diagnosed AML

2021
Show All
- Source
- Cite
- Save
Citations (0)
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (42)
Biomarker testing in non-small cell lung cancer in routine care: analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (9)
Four versus Two Years of Rituximab Maintenance (R-Maintenance) Following Bendamustine Plus Rituximab (B-R): Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN Study)

2018 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (3)
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

2018 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (25)
Intraperitoneal immunotherapy with the bispecific anti-EpCAM x anti-CD3 directed antibody catumaxomab for patients with peritoneal carcinomatosis from gastric cancer: Final results of a randomized phase II AIO trial.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Four Versus Two Years of Rituximab Maintenance (R-maintenance) Following Bendamustine Plus Rituximab (B-R): Initial Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN study)

2017 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Association of PIK3CA mutations and age with the occurence of second primary lung cancer (SPLC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)